Telmisartan increases vascular reparative capacity in older HIV-infected adults: a pilot study

Jordan E. LakeDivision of Infectious Diseases, Department of Medicine, University of California, Los Angeles, CA, USA

Sophie SeangDivision of Infectious Diseases, Department of Medicine, University of California, Los Angeles, CA, USACorrespondence[email protected]

Theodoros KelesidisDivision of Infectious Diseases, Department of Medicine, University of California, Los Angeles, CA, USA

Judith S. CurrierDivision of Infectious Diseases, Department of Medicine, University of California, Los Angeles, CA, USA

Otto O. YangDivision of Infectious Diseases, Department of Medicine, University of California, Los Angeles, CA, USA;Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, CA, USA;AIDS Healthcare Foundation, Los Angeles, CA, USA

Figures & data

Table 1 Baseline demographic and clinical characteristics

Download CSV Display Table

Table 2 EPC changes over 12 weeks of telmisartan therapy

Download CSV Display Table

Figure 1 Twelve-week changes in EPC number.

Figure 2 Twelve-week changes in EPC number stratified by baseline EPC number above (high) vs. below (low) the median value. *Results shown as mean ± standard error.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Telmisartan increases vascular reparative capacity in older HIV-infected adults: a pilot study

Table 1 Baseline demographic and clinical characteristics

Table 2 EPC changes over 12 weeks of telmisartan therapy

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Telmisartan increases vascular reparative capacity in older HIV-infected adults: a pilot study

Figures & data

Table 1 Baseline demographic and clinical characteristics

Table 2 EPC changes over 12 weeks of telmisartan therapy

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date